The Importance of Vitamin D in Mental Health

Oct 13, 2025 by windailys.com 122 views

The Effect of Collementary Supplementation on Levels of 25 (OH) D Serum and the Effectiveness of Therapy in Amphetamine Type Stimulant Users

Background

Vitamin D3: A Crucial Role in Brain Function and Neuropsychiatric Disorders

Collequalsiferol, or vitamin D3, plays a vital role in the development of brain function and is associated with various neuropsychiatric disorders. Research has shown that collecalsiferol is involved in several brain processes that can affect the treatment of psychological disorders. Given the importance of this vitamin, this study aims to investigate the effect of collectiferol's supplementation on levels of 25 (OH) D serum and the effectiveness of therapy in subjects that use amphetamine type stimulant (ATS).

The Importance of Vitamin D in Mental Health

Vitamin D and Mental Health: A Complex Relationship

Vitamin D has been linked to various mental health conditions, including depression, anxiety, and psychosis. Research has shown that vitamin D deficiency is common among individuals with mental health disorders. Given the crucial role of vitamin D in brain function, it is essential to investigate the effect of vitamin D supplementation on mental health outcomes in individuals who use ATS.

Research Purposes

Comparing Levels of 25 (OH) D Serum and Mental Health Outcomes

This study aims to compare levels of 25 (OH) d serum and scores from several mental health measurement scales, including positive and negative syndrome scale (Panss), Brief Psychiatric Rating Scale (BPRS), and Hamilton Anxiety Rating Scale (HARS) who receive a 1000 IU collectifierol supplementation compared to those who do not accept it.

Research Methods

An Experimental Quasi Design with Pre-Test and Post-Test Methods

This study uses an experimental quasi design with the pre-test and post-test methods and non-probability sampling of Consecutive types. As many as 50 Men ATS users who meet the inclusion and exclusion criteria are included in the study. Of this amount, 25 people received a 1000 IU collectiferol supplementation as an intervention group, while 25 other people became a control group that did not get a supplementation for 42 days. The level of 25 (OH) d serum is measured using Liaison 25 (OH) Total Assay (Diacorin) before and after treatment. To evaluate the psychosis condition, the PANSS and BPRS questionnaires are used, while the anxiety level is measured by Hars. The comparison between the two groups is carried out with a T-dependent test if the data is normally distributed, or with the Mann Whitney test if the data is not normally distributed. The results are considered significant if p <0.05.

Research Result

The Effect of Collequcaliserol Supplementation on Levels of 25 (OH) D Serum and Mental Health Outcomes

The results of statistical analysis show a significant difference in levels of 25 (OH) D serum after intervention in both groups, with an increase in levels of 25 (OH) higher serum in the intervention group. In addition, there is a significant decline in the scores of Panss, BPRS, and Hars in groups that receive collecalsiferol supplementation.

Conclusion

The Effectiveness of Collequcaliserol Supplementation in Amphetamine Type Stimulant Users

Giving a 1000 IU Collequcaliserol Supplement per day proved effective in increasing levels of 25 (OH) D serum and showing an increase in the effectiveness of therapy in ATS users. This is indicated by a significant decrease in serum cortisol levels and scores on the Panss, BPRS, and Hars scales. This finding provides new hopes in managing therapy for psychoactive substance users, by showing that collecalsiferol supplementation can contribute to improving their mental conditions.

Additional Analysis

The Importance of Vitamin D Supplementation in Therapy for Psychological Disorders

The findings of this study highlighted the importance of considering the supplementation of vitamin D in therapy for psychological disorders associated with the use of ATS. Considering the high prevalence of the use of ATS and its impact on mental health, the addition of collecalsiferol in the therapy regimen may be a valuable strategy. This not only helps in increasing levels of vitamin D in the body, but can also contribute to emotional stability and reduce psychological symptoms experienced by users.

Future Directions

The Relationship Between Nutrition and Mental Health

In a broader context, this research opens opportunities for further exploration of the relationship between nutrition, especially vitamin D, and mental health. More studies are needed to strengthen these findings and to determine the optimal dose and the duration of the supplementation needed to get the maximum benefit. Awareness of the importance of vitamin D as a component in the treatment of mental disorders should be a serious concern for health practitioners, especially in the treatment of patients who use illegal substances.

Limitations of the Study

Limitations of the Study

This study has several limitations. The sample size is relatively small, and the study duration is short. Additionally, the study only investigates the effect of collecalsiferol supplementation on levels of 25 (OH) D serum and mental health outcomes in ATS users. Further studies are needed to investigate the effect of collecalsiferol supplementation on other mental health outcomes and to determine the optimal dose and duration of supplementation.

Conclusion

The Effect of Collementary Supplementation on Levels of 25 (OH) D Serum and the Effectiveness of Therapy in Amphetamine Type Stimulant Users

In conclusion, this study provides evidence that collecalsiferol supplementation can increase levels of 25 (OH) D serum and improve mental health outcomes in ATS users. This finding has significant implications for the treatment of psychoactive substance users and highlights the importance of considering the supplementation of vitamin D in therapy for psychological disorders. Further studies are needed to strengthen these findings and to determine the optimal dose and duration of supplementation.
Q&A: The Effect of Collementary Supplementation on Levels of 25 (OH) D Serum and the Effectiveness of Therapy in Amphetamine Type Stimulant Users

Q: What is the purpose of this study?

A: The purpose of this study is to investigate the effect of collectiferol's supplementation on levels of 25 (OH) D serum and the effectiveness of therapy in subjects that use amphetamine type stimulant (ATS).

Q: What is the significance of vitamin D in mental health?

A: Vitamin D has been linked to various mental health conditions, including depression, anxiety, and psychosis. Research has shown that vitamin D deficiency is common among individuals with mental health disorders. Given the crucial role of vitamin D in brain function, it is essential to investigate the effect of vitamin D supplementation on mental health outcomes in individuals who use ATS.

Q: What is the research design of this study?

A: This study uses an experimental quasi design with the pre-test and post-test methods and non-probability sampling of Consecutive types. As many as 50 Men ATS users who meet the inclusion and exclusion criteria are included in the study.

Q: What is the intervention group and the control group in this study?

A: Of the 50 participants, 25 people received a 1000 IU collectiferol supplementation as an intervention group, while 25 other people became a control group that did not get a supplementation for 42 days.

Q: What are the outcomes measured in this study?

A: The level of 25 (OH) d serum is measured using Liaison 25 (OH) Total Assay (Diacorin) before and after treatment. To evaluate the psychosis condition, the PANSS and BPRS questionnaires are used, while the anxiety level is measured by Hars.

Q: What are the results of this study?

A: The results of statistical analysis show a significant difference in levels of 25 (OH) D serum after intervention in both groups, with an increase in levels of 25 (OH) higher serum in the intervention group. In addition, there is a significant decline in the scores of Panss, BPRS, and Hars in groups that receive collecalsiferol supplementation.

Q: What are the implications of this study?

A: This study provides evidence that collecalsiferol supplementation can increase levels of 25 (OH) D serum and improve mental health outcomes in ATS users. This finding has significant implications for the treatment of psychoactive substance users and highlights the importance of considering the supplementation of vitamin D in therapy for psychological disorders.

Q: What are the limitations of this study?

A: This study has several limitations. The sample size is relatively small, and the study duration is short. Additionally, the study only investigates the effect of collecalsiferol supplementation on levels of 25 (OH) D serum and mental health outcomes in ATS users. Further studies are needed to investigate the effect of collecalsiferol supplementation on other mental health outcomes and to determine the optimal dose and duration of supplementation.

Q: What are the future directions of this research?

A: In a broader context, this research opens opportunities for further exploration of the relationship between nutrition, especially vitamin D, and mental health. More studies are needed to strengthen these findings and to determine the optimal dose and the duration of the supplementation needed to get the maximum benefit. Awareness of the importance of vitamin D as a component in the treatment of mental disorders should be a serious concern for health practitioners, especially in the treatment of patients who use illegal substances.

Q: What are the recommendations for health practitioners?

A: Health practitioners should consider the supplementation of vitamin D in therapy for psychological disorders associated with the use of ATS. This not only helps in increasing levels of vitamin D in the body, but can also contribute to emotional stability and reduce psychological symptoms experienced by users.

Q: What are the recommendations for future research?

A: Future research should investigate the effect of collecalsiferol supplementation on other mental health outcomes and to determine the optimal dose and duration of supplementation. Additionally, research should explore the relationship between nutrition, especially vitamin D, and mental health in a broader context.